PEAK6’s ResMed RMD Stock Holding History

PEAK6’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.09M	Buy	+5,600	New	+$1.16M	﹤0.01%	1645
2026 Q1	–	Sell	-500	Closed	-$120K	–	3233
2025 Q4	$120K	Sell	500 -1,900	-79%	-$486K	﹤0.01%	2492
2025 Q3	$657K	Buy	2,400 +500	+26%	+$137K	﹤0.01%	2033
2025 Q2	$490K	Sell	1,900 -7,500	-80%	-$1.79M	﹤0.01%	2131
2025 Q1	$2.1M	Sell	9,400 -2,200	-19%	-$514K	﹤0.01%	1389
2024 Q4	$2.65M	Buy	+11,600	New	+$2.79M	0.01%	1253

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

PEAK6's RMD Position: Q2 2026 in Review

PEAK6 opened a new position in ResMed (RMD) in Q2 2026: 689 shares worth $134K. The stake represents ﹤0.01% of the portfolio and ranks #2356 among its holdings. This is a return to the name: PEAK6 previously reported a position in RMD as recently as Q1 2025.

PEAK6 first reported a position in RMD in Q4 2024 and has held it in 3 quarters since. The position peaked at $716K in Q4 2024. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

PEAK6 held 689 shares of ResMed worth $134K as of Q2 2026.
ResMed was a new PEAK6 position in Q2 2026.
ResMed made up ﹤0.01% of PEAK6's portfolio in Q2 2026, its #2356 holding.
PEAK6 first reported a position in ResMed in Q4 2024 and has held it in 3 quarters since.
PEAK6's ResMed position peaked at $716K in Q4 2024.
891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.